ALMOND (UNII: 3Z252A2K9G) (ALMOND - UNII:3Z252A2K9G), CASHEW (UNII: 3H5U5CX7KO) (CASHEW - UNII:3H5U5CX7KO), BRAZIL NUT (UNII: XKR79OET1K) (BRAZIL NUT - UNII:XKR79OET1K), PECAN (UNII: F14P91GB5F) (PECAN - UNII:F14P91GB5F), PEANUT (UNII: QE1QX6B99R) (PEANUT - UNII:QE1QX6B99R), COCONUT (UNII: 3RT3536DHY) (COCONUT - UNII:3RT3536DHY), BLACK WALNUT (UNII: 02WM57RXZJ) (BLACK WALNUT - UNII:02WM57RXZJ), ENGLISH WALNUT (UNII: 1V3SHR7QB7) (ENGLISH WALNUT - UNII:1V3SHR7QB7), COTTON SEED (UNII: DI0ZRJ0MXN) (COT - search results

United States - English - NLM (National Library of Medicine)

a-23- almond, cashew, brazil nut, pecan, peanut, coconut, black walnut, english walnut, cotton seed, flax seed, and sesame seed

dna labs, inc. - almond (unii: 3z252a2k9g) (almond - unii:3z252a2k9g), cashew (unii: 3h5u5cx7ko) (cashew - unii:3h5u5cx7ko), brazil nut (unii: xkr79oet1k) (brazil nut - unii:xkr79oet1k), pecan (unii: f14p91gb5f) (pecan - unii:f14p91gb5f), peanut (unii: qe1qx6b99r) (peanut - unii:qe1qx6b99r), coconut (unii: 3rt3536dhy) (coconut - unii:3rt3536dhy), black walnut (unii: 02wm57rxzj) (black walnut - unii:02wm57rxzj), english walnut (unii: 1v3shr7qb7) (english walnut - unii:1v3shr7qb7), cotton seed (unii: di0zrj0mxn) (cot - allergies.

United States - English - NLM (National Library of Medicine)

almond- prunus dulcis injection, solution apple- malus domestica injection, solution apricot- prunus armeniaca injection, solu

alk-abello, inc. - almond (unii: 3z252a2k9g) (almond - unii:3z252a2k9g) - almond 0.1 mg in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater